Cargando…
Stroke, Dementia, and Atrial Fibrillation: From Pathophysiologic Association to Pharmacological Implications
Autores principales: | Russo, Vincenzo, Vio, Riccardo, Proietti, Riccardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279210/ https://www.ncbi.nlm.nih.gov/pubmed/32397581 http://dx.doi.org/10.3390/medicina56050227 |
Ejemplares similares
-
Subclinical Atrial Fibrillation and Risk of Stroke: Past, Present and Future
por: AlTurki, Ahmed, et al.
Publicado: (2019) -
Clinical Evidence for the Choice of the Direct Oral Anticoagulant in Patients with Atrial Fibrillation According to Creatinine Clearance
por: Vio, Riccardo, et al.
Publicado: (2021) -
Novel nonpharmacologic approaches for stroke prevention in atrial fibrillation: results from clinical trials
por: Proietti, Riccardo, et al.
Publicado: (2015) -
The effect of atrial preference pacing
on atrial fibrillation electrophysiological
substrate in Myotonic Dystrophy type 1
population
por: RUSSO, VINCENZO, et al.
Publicado: (2014) -
Non-Pharmacological Stroke Prevention in Atrial Fibrillation
por: Anduaga, Iñigo, et al.
Publicado: (2023)